A Goldman Sachs note on what they see as a risk for the expected upcoming consumption boom.
- most severe downside risk is the evolution of a vaccine-resistant virus strain that would require a new vaccine
- although a new vaccine could be approved in less than five months, the consumption boom would likely be delayed until 2022
